RESUMEN

In March 2003, an international mulltidisciplinary group of scientists and clinicians with a specific interest in ovarian cancer met for 4 days to discuss research into and treatment of this challenging disease. Under the headings of molecular genetics, molecular biology, the biology of ovarian cancer, old therapies, new targets and the early detection of the disease, this Position Paper summarises the presentations and discussion from the 9th Biennial Helene Harris Memorial Trust Forum on Ovarian Cancer. In particular, we highlight the potential of international collaborations in translating laboratory science into useful clinical interventions.

Asunto(s)

Antineoplásicos/uso terapéutico , Inmunoterapia/métodos , Neoplasias Ováricas/terapia , Biomarcadores de Tumor , Femenino , Predicción , Expresión Génica , Genes BRCA1 , Genes BRCA2 , Genes Supresores de Tumor , Humanos , Mutación/genética , Neoplasias Ováricas/diagnóstico , Neoplasias Ováricas/genética , Ensayos Clínicos Controlados Aleatorios como Asunto